Vivanza Biosciences P/B Ratio
Vivanza Biosciences P/B ratio. Vivanza Biosciences (VIVANZA) P/B ratio is 1.22 (Moderate), book value per share ₹10.00 vs Healthcare average P/B of -0.3 — Moderate - Reasonably valued relative to book value. Browse VIVANZA cash flow statement for revenue, profit, balance sheet and cash flow data.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
VIVANZA P/B Ratio — Valuation Insights & Book Value Analysis
Vivanza Biosciences price-to-book ratio interpretation, valuation status and historical context — current P/B 1.22 (Moderate). Read Vivanza Biosciences dividend policy for the complete payout history and dividend yield track record.
- Current PB is 185.4% above historical average
- Trading at premium to sector average PB of -0.3
Vivanza Biosciences P/B Ratio Historical Trend
VIVANZA annual price-to-book ratio — 4 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Vivanza Biosciences share price screener.
VIVANZA Historical P/B Ratio — Book Value Per Share & Year-End Price
Vivanza Biosciences annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.14 | ₹10.0 | ₹1.44 | ₹4 | Low |
| 2025 | 0.22 | ₹10.0 | ₹2.20 | ₹4 | Low |
| 2024 | 0.27 | ₹12.5 | ₹3.42 | ₹5 | Low |
| 2023 | 1.08 | ₹10.0 | ₹10.77 | ₹4 | Moderate |
VIVANZA vs Healthcare Peers — P/B Ratio Comparison
Vivanza Biosciences P/B 1.22 vs Healthcare average -0.3, median 0.39 — range -7.62–0.89.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Chennai Meenakshi Multis… | CMMHOSP | -7.62 | ₹27 | Low |
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹39 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.75 | ₹128 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹43 | Low |